Primary |
Type 2 Diabetes Mellitus |
15.9% |
Ischaemic Heart Disease Prophylaxis |
13.2% |
Headache |
11.9% |
Back Pain |
7.9% |
Product Used For Unknown Indication |
6.6% |
Pain |
6.2% |
Myocardial Infarct Prophylaxis |
4.8% |
Arthritis |
4.0% |
Hypertension |
4.0% |
Analgesic Therapy |
3.5% |
Cardiac Disorder |
3.1% |
Cerebrovascular Accident Prophylaxis |
2.6% |
Diabetes Mellitus |
2.6% |
Migraine |
2.6% |
Anticoagulant Therapy |
2.2% |
Anxiety |
1.8% |
Arthralgia |
1.8% |
Atrial Fibrillation |
1.8% |
Coronary Artery Disease |
1.8% |
Muscle Spasms |
1.8% |
|
Drug Ineffective |
12.1% |
Off Label Use |
9.7% |
Myocardial Infarction |
8.1% |
Gastric Haemorrhage |
7.3% |
Haemorrhage |
7.3% |
Incorrect Drug Administration Duration |
6.5% |
Urticaria |
4.8% |
Epistaxis |
4.0% |
Rectal Haemorrhage |
4.0% |
Tinnitus |
4.0% |
Ulcer |
4.0% |
Drug Hypersensitivity |
3.2% |
Extra Dose Administered |
3.2% |
Loss Of Consciousness |
3.2% |
Nausea |
3.2% |
Therapeutic Response Unexpected |
3.2% |
Ulcer Haemorrhage |
3.2% |
Vomiting |
3.2% |
Weight Decreased |
3.2% |
Dyspnoea |
2.4% |
|
Secondary |
Headache |
13.1% |
Back Pain |
10.4% |
Pain |
10.0% |
Myocardial Infarct Prophylaxis |
8.0% |
Analgesic Therapy |
7.2% |
Pain In Extremity |
6.4% |
Toothache |
4.8% |
Arthralgia |
4.4% |
Product Used For Unknown Indication |
4.4% |
Arthritis |
4.0% |
Groin Pain |
3.2% |
Ischaemic Heart Disease Prophylaxis |
3.2% |
Muscle Spasms |
3.2% |
Pain Management |
3.2% |
Cerebrovascular Accident Prophylaxis |
2.8% |
Anticoagulant Therapy |
2.4% |
Migraine |
2.4% |
Nasopharyngitis |
2.4% |
Neck Pain |
2.4% |
Sinus Headache |
2.4% |
|
Drug Ineffective |
46.1% |
Off Label Use |
9.6% |
Incorrect Drug Administration Duration |
6.1% |
Overdose |
3.5% |
Therapeutic Response Unexpected |
3.5% |
Weight Decreased |
3.5% |
Incorrect Dose Administered |
2.6% |
Insomnia |
2.6% |
Muscle Spasms |
2.6% |
Tinnitus |
2.6% |
Arthralgia |
1.7% |
Gastric Disorder |
1.7% |
Gastric Ulcer |
1.7% |
Nausea |
1.7% |
Neck Pain |
1.7% |
Pain |
1.7% |
Pre-existing Condition Improved |
1.7% |
Rash |
1.7% |
Urticaria |
1.7% |
Ventricular Fibrillation |
1.7% |
|
Concomitant |
Ischaemic Heart Disease Prophylaxis |
26.7% |
Arthritis |
20.0% |
Analgesic Therapy |
6.7% |
Anticoagulant Therapy |
6.7% |
Arthralgia |
6.7% |
Back Pain |
6.7% |
Blood Cholesterol Abnormal |
6.7% |
Coagulopathy |
6.7% |
Headache |
6.7% |
Hypertension |
6.7% |
|
Incorrect Drug Administration Duration |
25.0% |
Extra Dose Administered |
12.5% |
Intentional Drug Misuse |
12.5% |
Off Label Use |
12.5% |
Throat Irritation |
12.5% |
Wheezing |
12.5% |
Wrong Technique In Drug Usage Process |
12.5% |
|
Interacting |
Ischaemic Heart Disease Prophylaxis |
57.1% |
Neuralgia |
14.3% |
Testicular Disorder |
14.3% |
Atrial Fibrillation |
7.1% |
Back Pain |
7.1% |
|
Rectal Haemorrhage |
50.0% |
Syncope |
25.0% |
Transient Ischaemic Attack |
25.0% |
|